Gaborone
Illuccix® Approved for Prostate Cancer Imaging in Brazil: First Marketing Authorization in Latin America
MELBOURNE,Australia andPORTO ALEGRE,Brazil,March 18,2025-- Telix Pharmaceuticals Limited (ASX: TLX,Nasdaq: TLX,Telix,the Company)today announces that the Brazilian Health Regulatory Agency (Agencia N
Mar 18, 2025